BOWIE, Md., April 25, 2018 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that it will hold a conference call for investors on Tuesday, May 8, 2018, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the company’s first quarter financial results, which will be announced via press release after the close of market trading on Tuesday, May 8, 2018.
The conference call can be accessed by dialing (855) 783-2604, conference ID 9884025; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.
About Inovalon
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Through the Inovalon ONE™ Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in petabyte volumes to arrive at sophisticated insights in real-time, drive impact wherever it is analytically identified best to intervene, and intuitively visualize data and information to inform business strategy and execution. Leveraging its platform, unparalleled proprietary data sets, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports a client base approaching 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 932,000 physicians, more than 455,000 clinical facilities, and 240 million Americans. For more information, visit www.inovalon.com.
Contacts:
Kim Collins
Phone: 301-809-4000 x1473
[email protected]
George Price (Investors)
Phone: 301-809-4000 x1190
[email protected]


Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
How Marco Pharma International Preserves German Homeopathic Traditions in America
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial 



